Skip to main content
Fig. 7 | Microbial Cell Factories

Fig. 7

From: In vitro and preclinical evaluation of the antifungal activity of 6-methoxy-1 H-indole-2-carboxylic acid produced by Bacillus toyonensis strain OQ071612 formulated as nanosponge hydrogel

Fig. 7

Photomicrographs of skin for Masson’s trichrome staining (MTC) of the different tested groups as follows: (a) unburned, uninfected, treated with MICA -NS-HG (skin irritation test; (b) Control, burned, infected, untreated; (c) control, burned, uninfected, untreated; (d) control, burned, infected, treated with vehicle (negative control hydrogel); (e) burned, infected, treated with MICA -NS-HG; (f) positive control-1, burned, infected, treated with Collagenase 0.6 IU (Iruxol®, Abbott Co., Wiesbaden, Germany); (g) positive control-2, burned, infected, treated with Isoconazole hydrogel (ISN) 1% (Candicure®, Al-Esraa Pharmaceutical Optima Co., EGYPT); (h) normal control group (intact, unburned, uninfected, untreated)

Back to article page